Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial of BMS-986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis.
Chest
; 154(5): 1061-1069, 2018 11.
Article
in En
| MEDLINE
| ID: mdl-30201408
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Vital Capacity
/
Cholecystitis
/
Respiratory System Agents
/
Receptors, Lysophosphatidic Acid
/
Idiopathic Pulmonary Fibrosis
/
Liver Function Tests
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Prognostic_studies
Limits:
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Chest
Year:
2018
Document type:
Article
Country of publication:
United States